Viewing StudyNCT00424983



Ignite Creation Date: 2024-05-05 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00424983
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2007-01-19

Brief Title: Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-11
Start Date Type: None
Primary Completion Date: 2009-11
Primary Completion Date Type: ACTUAL
Completion Date: 2009-11
Completion Date Type: ACTUAL
First Submit Date: 2007-01-19
First Submit QC Date: January 19 2007
Study First Post Date: 2007-01-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-12-17
Last Update Post Date: 2020-12-21
Last Update Post Date Type: ACTUAL